Page last updated: 2024-11-11

cinepazet

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID6434395
CHEMBL ID2110784
CHEBI ID135617
MeSH IDM0075395

Synonyms (25)

Synonym
cinepazet
CHEBI:135617
ethyl 2-[4-[(e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]piperazin-1-yl]acetate
einecs 245-927-3
cinepazetum [inn-latin]
cinepazeto [inn-spanish]
cinepazeto
unii-0lc95wwe9q
0lc95wwe9q ,
4-(1- oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl)-1-piperazineacetic acid, ethyl ester
cinepazet [inn:ban]
cinepazetum
ethyl 4-(3,4,5-trimethoxycinnamoyl)-1-piperazineacetate
cinepazet [who-dd]
1-piperazineacetic acid, 4-(1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl)-, ethyl ester
cinepazet [mi]
cinepazet [inn]
88053-11-6
CHEMBL2110784
AKOS024436028
ethyl cinepazate
ethyl (4-(3-(3,4,5-trimethoxyphenyl)acryloyl)-1-piperazinyl)acetate
DB13342
1-piperazineacetic acid, 4-[1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl]-, ethyl ester, (e)-
DTXSID901119699
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
alpha-amino acid esterThe amino acid ester derivative obtained the formal condensation of an alpha-amino acid with an alcohol.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.37 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.37)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (14.29%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]